These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 18596134

  • 1. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
    Panzer U, Zahner G, Wienberg U, Steinmetz OM, Peters A, Turner JE, Paust HJ, Wolf G, Stahl RA, Schneider A.
    Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
    [Abstract] [Full Text] [Related]

  • 2. [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells].
    Song Y, Lin Q, Zheng J, Zhu X, Yang S.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):673-6. PubMed ID: 25001926
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY, Kim HS.
    Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
    Seo SK, Seo DI, Park WS, Jung WK, Lee DS, Park SG, Choi JS, Kang MS, Choi YH, Choi I, Yu BC, Choi IW.
    Life Sci; 2014 Sep 01; 112(1-2):82-9. PubMed ID: 25072357
    [Abstract] [Full Text] [Related]

  • 5. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
    Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon H, Um JW, Sohn J, Song GG, Ji JD.
    Exp Mol Med; 2005 Jun 30; 37(3):179-85. PubMed ID: 16000871
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug 30; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells.
    Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD.
    J Immunol; 2000 Jun 15; 164(12):6503-8. PubMed ID: 10843708
    [Abstract] [Full Text] [Related]

  • 8. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
    Kanda N, Watanabe S.
    Endocrinology; 2007 May 15; 148(5):2317-25. PubMed ID: 17255201
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages.
    Kim HY, Kim HK, Kim JR, Kim HS.
    Immunol Cell Biol; 2005 Jun 15; 83(3):286-93. PubMed ID: 15877607
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW, Chang YH, Tsi CJ, Lin WW.
    J Immunol; 2003 Jul 15; 171(2):979-88. PubMed ID: 12847270
    [Abstract] [Full Text] [Related]

  • 11. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 15; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 12. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
    Arthritis Res Ther; 2005 Jun 15; 7(6):R1325-37. PubMed ID: 16277686
    [Abstract] [Full Text] [Related]

  • 13. 15-deoxy-delta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells.
    Imaizumi T, Kumagai M, Nishi N, Hirashima M, Hatakeyama M, Tamo W, Yoshida H, Nakamura T, Okumura K, Satoh K.
    Int Arch Allergy Immunol; 2003 May 15; 131(1):57-61. PubMed ID: 12759491
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
    Asano T, Wakisaka M, Yoshinari M, Iino K, Sonoki K, Iwase M, Fujishima M.
    Biochim Biophys Acta; 2000 Jun 02; 1497(1):148-54. PubMed ID: 10838168
    [Abstract] [Full Text] [Related]

  • 15. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS, Macedo P, Kilty IC, Barnes PJ, Donnelly LE.
    PLoS One; 2015 Jun 02; 10(6):e0128757. PubMed ID: 26090665
    [Abstract] [Full Text] [Related]

  • 16. 15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications.
    Si Q, Zhao ML, Morgan AC, Brosnan CF, Lee SC.
    J Immunol; 2004 Sep 01; 173(5):3504-13. PubMed ID: 15322215
    [Abstract] [Full Text] [Related]

  • 17. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
    Liu X, Yu H, Yang L, Li C, Li L.
    Eur J Cell Biol; 2012 Aug 01; 91(8):654-61. PubMed ID: 22560326
    [Abstract] [Full Text] [Related]

  • 18. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
    Reyes-Martin P, Ramirez-Rubio S, Parra-Cid T, Bienes-Martínez R, Lucio-Cazana J.
    Pharmacol Res; 2008 May 01; 57(5):344-50. PubMed ID: 18456507
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J, Cook JA, O'Connor M, Zingarelli B.
    Shock; 2007 Dec 01; 28(6):722-726. PubMed ID: 17621259
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan 01; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.